First Quadrant’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,726
Closed -$924K 404
2021
Q4
$924K Sell
29,726
-8,502
-22% -$284K 0.1% 172
2021
Q3
$1.46M Hold
38,228
0.17% 120
2021
Q2
$1.53M Hold
38,228
0.18% 119
2021
Q1
$1.66M Hold
38,228
0.18% 120
2020
Q4
$1.64M Buy
38,228
+9,784
+34% +$357K 0.16% 119
2020
Q3
$886K Sell
28,444
-10,444
-27% -$324K 0.11% 162
2020
Q2
$1.24M Sell
38,888
-3,719
-9% -$123K 0.17% 143
2020
Q1
$1.19M Buy
+42,607
New +$1.65M 0.17% 145
2019
Q1
Sell
-5,160
Closed -$271K 779
2018
Q4
$271K Buy
5,160
+3,058
+145% +$174K 0.02% 472
2018
Q3
$122K Buy
+2,102
New +$118K ﹤0.01% 689
2015
Q4
Sell
-800
Closed -$27K 817
2015
Q3
$27K Hold
800
﹤0.01% 724
2015
Q2
$26K Hold
800
﹤0.01% 723
2015
Q1
$29K Hold
800
﹤0.01% 692
2014
Q4
$24K Sell
800
-2,700
-77% -$79.1K ﹤0.01% 706
2014
Q3
$108K Hold
3,500
﹤0.01% 607
2014
Q2
$127K Buy
+3,500
New +$113K ﹤0.01% 616

Other funds holding OFIX

First Quadrant's OFIX Position: Q1 2022 in Review

First Quadrant sold out of Orthofix Medical (OFIX) in Q1 2022, closing a stake of 29,726 shares — an estimated $924K sold.

First Quadrant first reported a position in OFIX in Q2 2014 and held it in 16 quarters. The position peaked at $1.66M in Q1 2021. 149 funds tracked by Wall St. Rank hold OFIX as of Q1 2022.

  • First Quadrant reported no remaining Orthofix Medical position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 29,726 Orthofix Medical shares in Q1 2022, an estimated $924K.
  • First Quadrant first reported a position in Orthofix Medical in Q2 2014 and held it in 16 quarters.
  • First Quadrant's Orthofix Medical position peaked at $1.66M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.